All-trans retinoic acid decreases murine adipose retinol binding protein 4 production

Josep Mercader1, Nuria Granados, M Luisa Bonet

  • 1Laboratory of Molecular Biology, Nutrition and Biotechnology, Universitat de les Illes Balears, Palma de Mallorca, Spain.

Abstract

Insights

All-trans retinoic acid (ATRA) enhances insulin sensitivity by specifically reducing adipose retinol binding protein 4 (RBP4) expression in fat cells. This highlights vitamin A

Area of Science:

  • Metabolism and Endocrinology
  • Nutritional Biochemistry
  • Adipose Tissue Biology

Background:

  • Adipose-derived retinol binding protein 4 (RBP4) is implicated in insulin resistance.
  • Vitamin A metabolites, like retinoic acid, influence adipokines related to insulin sensitivity.
  • Understanding RBP4 regulation is crucial for metabolic health.

Purpose of the Study:

  • To investigate the impact of all-trans retinoic acid (ATRA) on adipose RBP4 production.
  • To explore the relationship between ATRA, RBP4, and insulin sensitivity.

Main Methods:

  • In vivo studies: ATRA treatment in mice, analyzing adipose tissue and liver RBP4 expression.
  • In vitro studies: ATRA exposure to 3T3-L1 adipocytes and primary adipocytes.
  • Assessed insulin sensitivity using the homeostatic model assessment for insulin resistance (HOMA-IR).

Main Results:

  • ATRA treatment improved insulin sensitivity in mice.
  • Adipose RBP4 mRNA and protein levels decreased following ATRA treatment.
  • ATRA reduced RBP4 mRNA in adipocytes dose-dependently, with similar effects from other retinoids.
  • Circulating RBP4 protein levels increased in ATRA-treated mice.

Conclusions:

  • ATRA selectively inhibits RBP4 expression in adipocytes.
  • Vitamin A metabolites can modulate insulin sensitivity via adipokine production.
  • These findings offer insights into vitamin A's role in metabolic regulation.

Related Concept Videos